EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS‐CoV‐2 infection

Yuexiu Zhang, Mijia Lu, Ilada Thongpan, Jiayu Xu, Mahesh Kc, Piyush Dravid, Sheetal Trivedi, Himanshu Sharma, Xueya Liang, Amit Kapoor, Mark E Peeples, Jianrong Li iD

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Yuexiu Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Measles virus (MeV) has been an excellent vector platform for delivering vaccines against many pathogens because of its high safety and efficacy, and induction of long‐lived immunity. Early in the COVID‐19 pandemic, a recombinant MeV (rMeV) expressing the prefusion full‐length spike protein stabilized by two prolines (TMV‐083) was developed and tested in phase 1 and 1/2 clinical trials but was discontinued because of insufficient immunogenicity and a low seroconversion rate in adults. Here, we compared the immunogenicity of rMeV expressing a soluble prefusion spike (preS) protein stabilized by two prolines (rMeV‐preS‐2P) with a rMeV expressing a soluble preS protein stabilized by six prolines (rMeV‐preS‐6P). We found that rMeV‐preS‐6P expressed approximately five times more preS than rMeV‐preS‐2P in cell culture. Importantly, rMeV‐preS‐6P induced 30‐60 and six times more serum immunoglobulin G and neutralizing antibody than rMeV‐preS‐2P, respectively, in IFNAR −/− mice. IFNAR −/− mice immunized with rMeV‐preS‐6P were completely protected from challenge with a mouse‐adapted SARS‐CoV‐2, whereas those immunized with rMeV‐preS‐2P were partially protected. In addition, hamsters immunized with rMeV‐preS‐6P were completely protected from the challenge with a Delta variant of SARS‐CoV‐2. Our results demonstrate that rMeV‐preS‐6P is significantly more efficacious than rMeV‐preS‐2P, highlighting the value of using preS‐6P as the antigen for developing vaccines against SARS‐CoV‐2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19CricetinaeAnimalsHumansMiceSARS-CoV-2COVID-19 VaccinesPandemicsSpike Glycoprotein, CoronavirusAntibodies, NeutralizingMeasles virusProlineAntibodies, Viral

Stichwörter der Autor:innen

SARS-CoV-2immunogenicityprefusion spikerecombinant measles virus

Substanzen

spike protein, SARS-CoV-2COVID-19 VaccinesSpike Glycoprotein, CoronavirusAntibodies, NeutralizingProlineAntibodies, Viral

Autor:innen und Institutionen

  • Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA.
  • Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
  • Infectious Disease Institute, The Ohio State University, Columbus, Ohio, USA.

ORCID-Profile: Jianrong Li

Förderung

  • NIAID NIH HHS

Zitieren

APA

Zhang, Y., Lu, M., Thongpan, I., Xu, J., Kc, M., Dravid, P., Trivedi, S., Sharma, H., Liang, X., Kapoor, A., Peeples, M. E., & Li, J. (2023). Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS‐CoV‐2 infection. Journal of Medical Virology. https://doi.org/10.1002/jmv.28687

Vancouver

Zhang Y, Lu M, Thongpan I, Xu J, Kc M, Dravid P, et al. Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS‐CoV‐2 infection. Journal of Medical Virology. 2023. doi:10.1002/jmv.28687

BibTeX
@article{Zhang2023,
  author = {Zhang, Yuexiu and Lu, Mijia and Thongpan, Ilada and Xu, Jiayu and Kc, Mahesh and Dravid, Piyush and Trivedi, Sheetal and Sharma, Himanshu and Liang, Xueya and Kapoor, Amit and Peeples, Mark E and Li, Jianrong},
  title = {Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS‐CoV‐2 infection},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28687}
}
Kostenlos starten →